WASHINGTON — Novo Nordisk CEO Lars Fruergaard Jørgensen will testify before the Senate after Sen. Bernie Sanders threatened to subpoena the company over its pricing of the popular diabetes drug ...

Novo Nordisk’ chief executive Lars Fruergaard Jørgensen has agreed to appear at a Senate ... representative in the GLP-1 agonist market to testify at the hearing. At ASCO 2025, BioNTech ...

June 14 (Reuters) - The Senate Committee on Health, Education, Labor, and Pensions said on Friday that Novo Nordisk (NOVOb.CO), opens new tab CEO Lars Jorgensen has agreed to testify voluntarily ...

The vote that was scheduled for next week was preempted with the announcement that Novo Nordisk CEO Lars Fruergaard Jørgensen had agreed to testify before the Senate Health, Education ...

Jørgensen has agreed to serve as the company’s CEO on an interim basis until his replacement is found. The Danish pharma giant added that Lars Rebien Sørensen, chair of the Novo Nordisk ...

Novo Nordisk is parting ways with its CEO Lars Fruergaard Jørgensen after the two parties mutually agreed that a change of leadership was required amid fierce glucagon-like peptide 1 receptor ...

U.S.-listed shares of Novo Nordisk declined in the opening minutes of trading Friday on the surprise news that CEO Lars Fruergaard Jørgensen is stepping down from the Danish drugmaker.

The Danish drugmaker on Friday abruptly announced that longtime CEO Lars ... of several of Novo Nordisk's other recent tie-ups. For example, Novo Nordisk in March said it had agreed to pay up ...